V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220004680 | 220015841 | null | 96.6 | Curative (C) | 2016-04-18 | 2017-06-27 | AML17 TRIAL | N | N | 220026573 | AML17 TRIAL |
| 220004681 | 220001857 | null | null | Palliative (P) | 2017-09-27 | 2017-09-28 | Cytarabine low (10to20mg/m2) IV/SC | 2 | N | 220026576 | CYTARABINE |
| 220004682 | 220001857 | 1.71 | 67.8 | Curative (C) | 2013-08-02 | 2013-08-03 | Trial Unspecified | Y | N | 220026576 | TRIAL |
| 220004686 | 220001860 | 0 | 75 | Palliative (P) | 2016-06-04 | 2016-06-04 | CYTARABINE | null | null | 220026587 | CYTARABINE |
| 220004687 | 220001860 | null | null | Palliative (P) | null | 2016-06-18 | Cytarabine low (10to20mg/m2) IV/SC | null | null | 220026587 | CYTARABINE |
| 220004688 | 220001860 | 1.69 | 67.2 | Palliative (P) | 2016-01-31 | 2016-02-04 | AML17 TRIAL | 2 | N | 220026587 | AML17 TRIAL |
| 220004689 | 220001861 | null | 68 | Disease modification (D) | 2014-05-30 | 2014-06-02 | Trial Unspecified | 01 | N | 220026595 | TRIAL |
| 220004690 | 220001861 | 1.65 | 58.4 | Not known (9) | 2014-08-21 | 2014-08-26 | Trial Unspecified | Y | N | 220026595 | TRIAL |
| 220004691 | 220001861 | 1.7 | 58 | Palliative (P) | 2016-07-26 | 2016-07-27 | Cytarabine Low Dose | 02 | N | 220026595 | CYTARABINE |
| 220004692 | 220001861 | 1.48 | 58.4 | Not known (9) | 2016-11-07 | 2016-11-07 | Trial Unspecified | Y | N | 220026595 | TRIAL |
| 220004693 | 220020284 | null | 86 | Palliative (P) | 2016-06-19 | 2016-06-19 | Trial Unspecified | Y | N | 220026599 | TRIAL |
| 220004694 | 220020284 | null | 69 | Curative (C) | 2016-01-21 | 2016-01-21 | AML17 TRIAL | N | N | 220026599 | AML17 TRIAL |
| 220004695 | 220001862 | 1.58 | null | Disease modification (D) | null | 2015-05-08 | Cytarabine Low Dose | 2 | null | 220026603 | CYTARABINE |
| 220004696 | 220010952 | 1.73 | null | Not known (9) | 2013-08-30 | 2014-09-01 | Cytarabine Low Dose | N | N | 220026604 | CYTARABINE |
| 220004697 | 220010952 | 1.74 | 100 | Palliative (P) | 2013-11-06 | 2014-05-29 | Cytarabine Low Dose | N | N | 220026604 | CYTARABINE |
| 220004698 | 220001863 | 1.69 | 0 | null | 2015-07-27 | 2015-09-07 | Cytarabine Low Dose | 02 | N | 220026608 | CYTARABINE |
| 220004699 | 220010953 | 1.59 | 59.4 | Curative (C) | 2016-02-08 | 2016-02-14 | AML17 TRIAL | N | N | 220026609 | AML17 TRIAL |
| 220004700 | 220001864 | 0 | null | Adjuvant (A) | 2017-02-20 | 2017-02-20 | CYTARABINE | 02 | N | 220026611 | CYTARABINE |
| 220004701 | 220001864 | null | 80 | null | 2014-07-26 | 2014-09-27 | AML17 TRIAL | Y | N | 220026611 | AML17 TRIAL |
| 220004702 | 220001865 | 0 | 81.6 | null | 2013-11-22 | 2013-11-22 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 220026613 | CYTARABINE |
| 220004703 | 220001866 | 1.53 | 73.2 | Curative (C) | 2013-08-27 | 2013-08-27 | AML17 TRIAL | null | N | 220026614 | AML17 TRIAL |
| 220004704 | 220001867 | 0 | 102 | null | 2016-04-30 | 2016-05-07 | Trial Unspecified | 01 | N | 220026621 | TRIAL |
| 220004705 | 220001867 | null | 56.8 | null | 2013-07-19 | 2013-07-19 | AML17 TRIAL | 2 | N | 220026621 | AML17 TRIAL |
| 220004706 | 220001867 | 1.87 | 102.7 | Curative (C) | 2018-01-01 | 2018-01-04 | AML17 TRIAL | Y | N | 220026621 | AML17 TRIAL |
| 220004708 | 220001869 | null | 115.4 | Curative (C) | 2018-01-09 | 2018-01-23 | Trial Unspecified | Y | N | 220026632 | TRIAL |
| 220004709 | 220001870 | null | 69.4 | Curative (C) | 2014-08-10 | 2014-08-10 | AML17 TRIAL | 1 | N | 220026634 | AML17 TRIAL |
| 220004710 | 220001870 | null | 87.7 | Palliative (P) | 2014-11-04 | 2014-11-04 | Trial Unspecified | 01 | N | 220026634 | TRIAL |
| 220004711 | 220001870 | null | null | Radical (R) | 2014-05-08 | 2014-05-21 | Trial Unspecified | Y | N | 220026634 | TRIAL |
| 220004712 | 220001870 | 1.7 | 67.55 | Palliative (P) | 2017-06-02 | 2017-07-16 | Cytarabine Low Dose | 2 | N | 220026634 | CYTARABINE |
| 220004713 | 220001870 | 1.72 | 92 | Curative (C) | 2014-02-14 | 2014-03-24 | AML17 TRIAL | Y | N | 220026634 | AML17 TRIAL |
| 220004714 | 220001871 | 1.41 | 70 | Palliative (P) | 2017-05-07 | 2017-05-24 | CYTARABINE | N | null | 220026642 | CYTARABINE |
| 220004715 | 220001872 | 1.77 | null | Curative (C) | 2017-01-13 | 2017-01-18 | CYTARABINE | 02 | N | 220026644 | CYTARABINE |
| 220004717 | 220001873 | 1.66 | null | Palliative (P) | 2016-03-27 | 2016-04-03 | Cytarabine Low Dose | 2 | N | 220026649 | CYTARABINE |
| 220004718 | 220001873 | 1.63 | null | Disease modification (D) | 2013-11-03 | 2013-11-15 | CYTARABINE | N | N | 220026649 | CYTARABINE |
| 220004719 | 220001874 | 1.52 | 75 | Curative (C) | 2014-07-05 | 2014-07-10 | AML17 TRIAL | N | Y | 220026651 | AML17 TRIAL |
| 220004720 | 220001874 | 1.5 | null | Palliative (P) | 2016-11-19 | 2016-11-26 | Cytarabine Low Dose | 02 | null | 220026651 | CYTARABINE |
| 220004721 | 220015847 | 1.78 | 85 | Curative (C) | 2013-12-13 | 2013-12-13 | AML17 TRIAL | Y | N | 220026663 | AML17 TRIAL |
| 220004722 | 220015847 | null | 45 | Curative (C) | 2017-02-04 | 2017-02-04 | Cytarabine Low Dose | N | N | 220026663 | CYTARABINE |
| 220004723 | 220015847 | 1.79 | 59.8 | Not known (9) | 2016-02-11 | 2016-02-11 | Trial Unspecified | Y | N | 220026663 | TRIAL |
| 220004724 | 220015847 | 1.67 | 69 | Curative (C) | 2016-03-19 | 2016-03-22 | Trial Unspecified | Y | N | 220026663 | TRIAL |
| 220004725 | 220015847 | 1.81 | 65.5 | Disease modification (D) | 2016-05-07 | 2016-05-10 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 220026663 | CYTARABINE |
| 220004726 | 220015847 | 1.68 | null | Palliative (P) | 2019-03-02 | 2019-03-02 | Cytarabine Low Dose | N | N | 220026663 | CYTARABINE |
| 220004727 | 220022151 | 1.79 | 94 | Curative (C) | 2014-12-08 | 2014-12-08 | Trial Unspecified | 1 | null | 220026676 | TRIAL |
| 220004728 | 220022151 | 1.73 | 100 | Palliative (P) | 2013-07-17 | 2013-07-28 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220026676 | CYTARABINE |
| 220004729 | 220022151 | 1.83 | null | Curative (C) | 2014-11-21 | 2014-11-21 | AML17 TRIAL | N | N | 220026676 | AML17 TRIAL |
| 220004730 | 220022317 | 1.66 | 70 | Palliative (P) | 2016-03-22 | 2016-03-22 | Trial Unspecified | 1 | N | 220026681 | TRIAL |
| 220004731 | 220001875 | 1.5 | null | Curative (C) | 2013-04-24 | 2013-04-24 | Trial Unspecified | 1 | N | 220026683 | TRIAL |
| 220004732 | 220010960 | 1.6 | 56.5 | null | 2017-11-09 | 2017-11-16 | AML17 TRIAL | 02 | null | 220026684 | AML17 TRIAL |
| 220004733 | 220010960 | null | 42 | Curative (C) | 2015-10-10 | 2015-10-11 | AML17 TRIAL | 1 | null | 220026684 | AML17 TRIAL |
| 220004734 | 220001876 | 0 | 39.5 | Palliative (P) | 2013-06-03 | 2013-06-03 | Cytarabine Low Dose | 02 | N | 220026687 | CYTARABINE |